INTERMOLECULAR INC — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/17b6d718-7c27-43f1-b7cf-a46c35025b77/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2018 | $33.7M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-007009 |
| FY 2017 | $37.2M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-007009 |
| FY 2016 | $47.3M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-003326 |
| FY 2015 | $45.3M | 2015-01-01 – 2015-12-31 | evidence 0001558370-16-004422 |
| FY 2014 | $47.7M | 2014-01-01 – 2014-12-31 | evidence 0001311241-15-000022 |
| FY 2013 | $67.4M | 2013-01-01 – 2013-12-31 | evidence 0001311241-14-000050 |
| FY 2012 | $66.8M | 2012-01-01 – 2012-12-31 | evidence 0001311241-13-000056 |
| FY 2011 | $53.8M | 2011-01-01 – 2011-12-31 | evidence 0001311241-13-000056 |
| FY 2010 | $42.7M | 2010-01-01 – 2010-12-31 | evidence 0001311241-13-000056 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
INTERMOLECULAR INC — all facts · Net Income · Operating Income